Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of alfentanil in children undergoing tonsillectomy and adenoidectomy
ChiCTR2000035029Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alfentanil in Tonsillar hyperplasia and adenoidal hypertrophy (3 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoint: Helbo-Hansen score. Started Aug 2020; status: recruiting.
02
Drugs
alfentanil
03
Conditions
Tonsillar hyperplasiaadenoidal hypertrophy
Beyond the preview
Go deeper on ChiCTR2000035029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035029.